Many seriously ill people die waiting for the FDA to approve drugs that regulators in other advanced countries have already ...

Expediting the review process allows for appropriately timed advice and implementing adjustments that considerably reduce the ...

PTC Therapeutics' gene therapy is already approved in the European Union, Great Britain, and Israel. The drugmaker will also ...

I noted that low-profit drugs often have just one or two domestic producers, making us vulnerable to supply disruptions from ...

She also offered strategies to streamline the process and reduce the strain on the developer ... the drug developer submits ...

The rise of antibody therapeutics is transforming drug discovery, providing highly specific treatments for complex diseases ...

On World Diabetes Day, it's worth taking a look back at the last 10.5 months in the diabetes technology space.

Good morning and welcome to ImmuCell Corporation Reports Third Quarter September 30, 2024, Unaudited Financial Results Conference Call. All participants will be in listen-only mode. After today’s ...

FDA approval to begin pivotal trial of fully implanted cochlear ... The Acclaim Cochlear Implant received the Breakthrough Device Designation from the U.S. Food and Drug Administration (FDA) in 2019.

While there has been progress with electronic health records and digitalisation, there is a need for better patient ...

The US Food and Drug Administration (FDA) has granted accelerated approval for PTC Therapeutics’ KEBILIDI, the first gene ...